Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Hims & Hers to sell Lilly's weight-loss drug on its telehealth platform (April 1)
By Sneha S K and Puyaan Singh April 1 (Reuters) - Telehealth firm Hims & Hers Health HIMS.N said on Tuesday it plans to sell Eli Lilly's LLY.N weight-loss drug, as it widens its offerings to offset any impact from impending restrictions on selling copies of Novo Nordisk's obesity dru...
Reuters
Wed, Apr 2
LIVE MARKETS-Watch out for an uptick in U.S. April data
STOXX 600 down 0.8%Trump tariffs due at 2000 GMTWall St futures downWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com.WATCH OUT FOR AN UPTICK IN U.S. APRIL DATA Yes, we're all ...
Reuters
Wed, Apr 2
UK shares fall as markets brace for potential US tariffs
FTSE 100 down 0.8%, FTSE 250 fell 0.7%UK healthcare sector hits near two-month low ahead of tariffs April 2 (Reuters) - UK shares retreated on Wednesday as global markets braced for details of U.S. President Donald Trump's reciprocal tariffs that has fueled concerns about an escalating trade...
Reuters
Wed, Apr 2
These 2 Vanguard ETFs Have Over 10% of Assets in Nvidia Stock. Here's Why Both Growth Funds Are Great Buys Now.
Nvidia (NASDAQ: NVDA) took the market by storm in 2023 and 2024 -- increasing by several-fold in just two years to become the third most valuable company in the world behind only Apple (NASDAQ: AAPL) and Microsoft (NASDAQ: MSFT). But Nvidia and several other megacap growth stocks are underperforming...
The Motley Fool
Wed, Apr 2
Mizuho starts coverage on Sitio Royalties with 'neutral' rating
** Brokerage Mizuho starts coverage on royalty holder Sitio Royalties Corp STR.N with "neutral" rating and $23 PT, a ~15% upside to the stock's last close** Says STR has a "quality portfolio of mineral and royalty interests" mainly in the Permian Basin** Co's key challenge is...
Reuters
Wed, Apr 2
23% of Warren Buffett's Portfolio Is Invested in This 1 AI Stock
Warren Buffett and his crew at Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) have one of the best investment track records of all time. Few investors have been able to match Buffett's success over Berkshire's long history.However, Berkshire hasn't achieved this success by investing in flashy tech s...
The Motley Fool
Wed, Apr 2
Truist falls on Raymond James cut to "market perform"
** U.S. lender Truist Financial's shares TFC.N fall 1.2% to $40.51 premarket** Raymond James downgrades to "market perform" from "outperform"** Says the lender's path to improving profitability is increasingly challenged under current market conditions** "While management...
Reuters
Wed, Apr 2
RBC cuts Beacon Roofing Supply rating on QXO offer price
** RBC Capital Markets lowers rating of Beacon Roofing Supply BECN.O to "sector perform" from "outperform"** Lifts price target by 35 cents to $124.35, representing a 0.5% upside to the stock's last close** Says rating and PT change are to match acquisition price offered by QXO Q...
Reuters
Wed, Apr 2
MORNING BID AMERICAS-Trouble with a capital 'T'
By Mike Dolan LONDON, April 2 (Reuters) - What matters in U.S. and global markets todayBy Mike Dolan, Editor-At-Large, Financial Industry and Financial Markets The bigger the buildup to an event, the greater the risk of disappointment. Wednesday's much-heralded U.S. tariff announcements m...
Reuters
Wed, Apr 2
Why April Could Be a Huge Month for Eli Lilly Stock
Eli Lilly (NYSE: LLY) is the most valuable healthcare company in the world, worth more than $700 billion. Over the past 12 months, however, the stock's performance has been fairly lackluster, rising by just around 6%. Investors are beginning to scoff at its expensive price tag, with Eli Lilly tradin...
The Motley Fool
Wed, Apr 2
Down 28%, Should You Buy the Dip on Nvidia?
Few technologies captured the market's attention quite like artificial intelligence (AI) over the course of the last few years. It comes as no surprise, however, given the enormity of the technology's potential power -- at least according to its ambassadors. The Sam Altmans (CEO of OpenAI) and Dario...
The Motley Fool
Wed, Apr 2
Better Buy: XRP vs Bitcoin
The crypto market is abuzz after a bit of a lull in March. Things are getting active and volatile again.For example, Bitcoin (CRYPTO: BTC) is up 3% in five hours as I'm writing this in the morning of March 31. The oldest and largest cryptocurrency is also down 5% in the last week and 7% in a month.W...
The Motley Fool
Wed, Apr 2
NCino plummets after annual outlook, Q4 EPS miss
** Shares of nCino NCNO.O plummet 33.3% premarket to $18.75, a record low, after banking software firm's current year guidance and qtrly earnings miss consensus** NCNO on course for record daily pct decline, if loss holds** Wilmington, North Carolina-based firm late Tues projected FY26 adj EPS o...
Reuters
Wed, Apr 2
LIVE MARKETS-US Treasuries will follow stocks on April 2
STOXX 600 down 0.7%Trump tariffs due at 2000 GMTWall St futures downWelcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com.US TREASURIES WILL FOLLOW STOCKS ON APRIL 2U.S. Treasury yields fe...
Reuters
Wed, Apr 2
Should You Buy the Vanguard S&P 500 ETF -- or One of These 3 Great ETFs Instead?
The Vanguard S&P 500 ETF (NYSEMKT: VOO) is one of the largest index funds in the world and can be an excellent backbone to any investment strategy. However, there are some alternative ways to get broad stock market exposure, and here are three ETFs in particular that could be a good fit for you.*Sto...
The Motley Fool
Wed, Apr 2
Jefferies starts coverage on CenterPoint Energy with 'buy' rating
** Brokerage Jefferies starts coverage on utility CenterPoint Energy CNP.N with "buy" rating and $42 PT, citing a "compelling re-rating story"** PT represents a 14% upside to the stock's last close** Brokerage expects strong earnings growth, driven by CNP's history of "me...
Reuters
Wed, Apr 2
Charles Schwab rises after Citi upgrades to 'buy'
** Shares of brokerage firm Charles Schwab SCHW.N rise 1.4% to $78.78 in premarket trading** Citi Research upgrades SCHW to "buy" from "neutral"; raises PT to $102 from $85, implying a 31.3% upside to stock's last close** Brokerage sees accelerating net new assets (NNA) growth in...
Reuters
Wed, Apr 2
2 Growth Stocks and 1 ETF to Buy Even If the Stock Market Keeps Falling in 2025
So far, 2025 hasn't been a great year for growth stocks. At the time of this writing, the growth-heavy Nasdaq Composite is down by more than 10% year to date -- underperforming the S&P 500 and Dow Jones Industrial Average -- both of which are also down, but by lesser degrees. However, growth stocks ...
The Motley Fool
Wed, Apr 2
Is Apple Pay really a problem for PayPal? Wall Street analyst weighs in
Investing.com -- Losing market share to Apple (NASDAQ:AAPL) Pay remains the largest overhang for PayPal (NASDAQ:PYPL), but Mizuho analyst believes these concerns may be overstated.With more than 80% o
Investing.com
Wed, Apr 2
Billionaire Stanley Druckenmiller Sold Nvidia and Broadcom and Is Buying This Spectacular Artificial Intelligence (AI) Stock Instead
Stanley Druckenmiller has a knack for identifying global investing trends. When he finds something interesting, the billionaire investor isn't afraid to bet big on it.Such was the case in late 2022, when he started buying a huge stake in Nvidia as OpenAI launched ChatGPT. By the next summer he had a...
The Motley Fool
Wed, Apr 2
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free